Recorded Chinese product: 注射用穿琥宁注射用穿琥宁
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 哈尔滨圣泰生物制药有限公司Chinese legal name: 哈尔滨圣泰生物制药有限公司
主要成分Active Ingredients
- 穿琥宁Chuanhu Ning
药物知识说明
穿琥宁是一种在国家药监局注册认定的药品。该药品含有穿琥宁-6bb3722e等成分。
该药品关联的活性成分包括:穿琥宁Chuanhu Ning。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:哈尔滨圣泰生物制药有限公司Chinese legal name: 哈尔滨圣泰生物制药有限公司。
您可以探索含有相同成分的其他药品:穿琥宁-6bb3722e成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用穿琥宁) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 穿琥宁Chuanhu Ning.
Manufacturers recorded for this product: 哈尔滨圣泰生物制药有限公司Chinese legal name: 哈尔滨圣泰生物制药有限公司.
Explore other medicines containing the same ingredient: 穿琥宁 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用穿琥宁Recorded Chinese product: 注射用穿琥宁
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100mg100 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 哈尔滨圣泰生物制药有限公司Chinese legal name: 哈尔滨圣泰生物制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H23022854
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H23022854
Manufacturer
Chinese legal name: 哈尔滨圣泰生物制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H23022854
生产企业
哈尔滨圣泰生物制药有限公司(国产)
适应症
用于病毒性肺炎,病毒性上呼吸道感染等。
用法用量
1.肌内注射一次l00mg,一日1~2次,小儿酌减或遵医嘱。 2.静脉滴注一日400~800mg,用氯化钠注射液分2次稀释后滴注,每次不得过400mg,小儿酌减,或遵医嘱。 临用前加氯化钠注射液适量溶解。
不良反应
静脉滴注后可发生过敏性休克,血小板减少,也可发生皮肤过敏(如药疹等),小儿腹泻,肝功能损害,血管刺激疼痛,胃肠不适。呼吸困难,寒战,发热等。
禁忌
对本品过敏者禁用。
注意事项
1.近年在临床应用中,本品过敏反应有上升趋势,在使用过程中如有发热、憋气现象,应立即停止用药。一旦出现过敏性休克表现,立即采取相应的急救措施。2.药物性状改变时禁止使用。3.用药过程应定期检查血象,发现血小板减少应及时停药,并给予相应处理。
贮藏
密闭,在阴凉干燥处(不超过20℃)保存。
规格
100mg
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.